BioNanomatrix has changed its name to BioNano Genomics.  By adopting the new name, the company is communicating its position as a solution provider for genomics researchers who want to fully understand the biology of the genomes at the core of their research.  The change follows the recent establishment of new corporate headquarters in San Diego, the appointment of new leadership, and additional new investment.

The corporate re-branding reflects the company’s expanding focus on delivering genomic applications for its nanoAnalyzer system, a platform that uses single-molecule imaging to visualize extremely long nucleic acids and reveal genome architecture in its native state. BioNano Genomics makes full genome understanding more accessible to researchers and clinicians who seek simpler ways of examining whole genomes while extending their investigations beyond the realm of variation at the level of only a few nucleotides.

"The change reflects the next evolution of our company as we commercialize a platform that complements and extends the reach of existing genomic technologies by providing the long-range view of genomic variation," said BioNano Genomics president and CEO Dr. R. Erik Holmlin, "BioNano Genomics is intensely focused on helping the research community achieve a more comprehensive understanding of genome biology by developing insight into how the different components of a genome are organized.  This understanding should provide the context that has been missing in our understanding of the link between phenotypic variation and genomic variation."